OFFICER] STOCK OPTION AWARD granted under Appendix B to the OXFORD IMMUNOTEC GLOBAL PLCStock Option Agreement • February 3rd, 2014 • Oxford Immunotec Global PLC • In vitro & in vivo diagnostic substances
This agreement (this “Agreement”) evidences a stock option granted by Oxford Immunotec Global PLC (the “Company”) to the undersigned (the “Optionee”) pursuant to the Company’s 2013 Share Incentive Plan and Appendix B thereto (together, as amended from time to time, the “Plan”).
